Pharmaceutical Preparations · CIK 1781174
Develops precision oncology medicines matched to patients via a proteomics-based platform
Comparable business profile · signals at a glance
In the 90 days to Jan 14, 2026: 3 insiders bought $115K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 14, 2026 | Blume-Jensen PeterPresident and CEO | Buy | 49,000 | $1.68 | $82K |
| Jan 14, 2026 | Levy Adam D.Chief Financial Officer | Buy | 8,832 | $1.70 | $15K |
| Jan 13, 2026 | Devroe EricChief Operating Officer | Buy | 10,000 | $1.72 | $17K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.